Torthaí cuardaigh - Annette Langer‐Gould
- 1 - 20 toradh as 33 á dtaispeáint
- Téigh chuig an gcéad leathanach eile
-
1
Validation of the Swedish Multiple Sclerosis Register de réir Peter Alping, Fredrik Piehl, Annette Langer‐Gould, Thomas Frisell
Foilsithe / Cruthaithe 2018Artigo -
2
Multiple sclerosis, rituximab, and COVID‐19 de réir Annette Langer‐Gould, Jessica B. Smith, Bonnie H. Li
Foilsithe / Cruthaithe 2021Artigo -
3
Childhood obesity and risk of pediatric multiple sclerosis and clinically isolated syndrome de réir Annette Langer‐Gould, Sonu M. Brara, Brandon Beaber, Corinna Koebnick
Foilsithe / Cruthaithe 2013Artigo -
4
Multiple Sclerosis, Rituximab, Hypogammaglobulinemia, and Risk of Infections de réir Annette Langer‐Gould, Bonnie H. Li, Jessica Smith, Stanley Xu
Foilsithe / Cruthaithe 2024Artigo -
5
Pediatric Idiopathic Intracranial Hypertension and Extreme Childhood Obesity de réir Sonu M. Brara, Corinna Koebnick, Amy H. Porter, Annette Langer‐Gould
Foilsithe / Cruthaithe 2012Artigo -
6
Oral Contraceptives and Multiple Sclerosis/Clinically Isolated Syndrome Susceptibility de réir Kerstin Hellwig, Lie H. Chen, Frank Z Stancyzk, Annette Langer‐Gould
Foilsithe / Cruthaithe 2016Artigo -
7
Analysis of Rituximab Use, Time Between Rituximab and SARS-CoV-2 Vaccination, and COVID-19 Hospitalization or Death in Patients With Multiple Sclerosis de réir Jessica B. Smith, Edlin Gonzales, Bonnie H. Li, Annette Langer‐Gould
Foilsithe / Cruthaithe 2022Artigo -
8
Progressive Multifocal Leukoencephalopathy in a Patient Treated with Natalizumab de réir Annette Langer‐Gould, Scott W. Atlas, Ari Green, Andrew W. Bollen, Daniel Pelletier
Foilsithe / Cruthaithe 2005Artigo -
9
Multiple Sclerosis, Disease-Modifying Therapies, and Infections de réir Annette Langer‐Gould, Jessica B. Smith, Edlin Gonzales, Fredrik Piehl, Bonnie H. Li
Foilsithe / Cruthaithe 2023Artigo -
10
Incidence of acquired CNS demyelinating syndromes in a multiethnic cohort of children de réir Annette Langer‐Gould, J.L. Zhang, Joanie Chung, Y. Yeung, Emmanuelle Waubant, Yao Jianhua
Foilsithe / Cruthaithe 2011Artigo -
11
Racial and Ethnic Disparities in Multiple Sclerosis Prevalence de réir Annette Langer‐Gould, Edlin Gonzales, Jessica B. Smith, Bonnie H. Li, Lorene M. Nelson
Foilsithe / Cruthaithe 2022Artigo -
12
Rituximab, MS, and pregnancy de réir Jessica B. Smith, Kerstin Hellwig, Katharina Fink, Deirdre J. Lyell, Fredrik Piehl, Annette Langer‐Gould
Foilsithe / Cruthaithe 2020Artigo -
13
Environmental and genetic risk factors for MS: an integrated review de réir Emmanuelle Waubant, Robyn Lucas, Ellen M. Mowry, Jennifer Graves, Tomas Olsson, Lars Alfredsson, Annette Langer‐Gould
Foilsithe / Cruthaithe 2019Revisão -
14
Breastfeeding, ovulatory years, and risk of multiple sclerosis de réir Annette Langer‐Gould, Jessica B. Smith, Kerstin Hellwig, Edlin Gonzales, Samantha Haraszti, Corinna Koebnick, Anny H. Xiang
Foilsithe / Cruthaithe 2017Artigo -
15
Safety of potential breast milk exposure to IFN-β or glatiramer acetate de réir Andrea I. Ciplea, Annette Langer‐Gould, Anna Ståhl, Sandra Thiel, Annette Queißer-Wahrendorf, Ralf Gold, Kerstin Hellwig
Foilsithe / Cruthaithe 2020Artigo -
16
-
17
Monoclonal antibody treatment during pregnancy and/or lactation in women with MS or neuromyelitis optica spectrum disorder de réir Andrea I. Ciplea, Annette Langer‐Gould, Annick de Vries, Tiny Schaap, Sandra Thiel, Marius Ringelstein, Ralf Gold, Kerstin Hellwig
Foilsithe / Cruthaithe 2020Artigo -
18
Exclusive Breastfeeding and the Effect on Postpartum Multiple Sclerosis Relapses de réir Kerstin Hellwig, Milena Rockhoff, Sandra Herbstritt, Nadja Borisow, Aiden Haghikia, Birte Elias-Hamp, Sylvia Menck, Ralf Gold, Annette Langer‐Gould
Foilsithe / Cruthaithe 2015Artigo -
19
Multiple Sclerosis Disease Activity and Disability Following Discontinuation of Natalizumab for Pregnancy de réir Kerstin Hellwig, Marianne Tokic, Sandra Thiel, Nina Esters, Charlotte Spicher, Nina Timmesfeld, Andrea I. Ciplea, Ralf Gold, Annette Langer‐Gould
Foilsithe / Cruthaithe 2022Artigo -
20
Early identification of COVID-19 cytokine storm and treatment with anakinra or tocilizumab de réir Annette Langer‐Gould, Jessica B. Smith, Edlin Gonzales, Rhina D. Castillo, Judith Garza Figueroa, Anusha Ramanathan, Bonnie H. Li, Michael K. Gould
Foilsithe / Cruthaithe 2020Artigo
Uirlisí cuardaigh:
Ábhair a bhaineann le hábhar
Medicine
Internal medicine
Multiple sclerosis
Immunology
Biology
Cohort
Pediatrics
Disease
Environmental health
Population
Genetics
Confidence interval
Obstetrics
Sociology
Demography
Pregnancy
Retrospective cohort study
Psychiatry
Cohort study
Rituximab
Natalizumab
Physics
Anthropology
Breastfeeding
Ethnic group
Incidence (geometry)
Lymphoma
Odds ratio
Optics
Pathology